News
Fran Lasowski and Renaud JACQUEMART are looking forward to attending OIS XIII in San Diego on December 1 & 2, 2023. If you're going to be there, let's meet up!
For more, click here.
Great to network and get IP info from Maura Campbell at the Ontario Bioscience Innovation Organization (OBIO) Breakfast series this morning.
For more, click here.
Fran Lasowski looking very much excited to start networking at this weeks BIO-Europe in Munich. If you're here, let's meet up!
For more, click here.
Fran Lasowski and Renaud JACQUEMART will be at CPHI in Barcelona – a flagship trade show of the international pharmaceutical industry, between October 24th to 26th. Reach out if you’d like to connect!
For more, click here.
Fran Lasowski and Renaud JACQUEMART, PhD, MBA are attending the 2023 BIO International Convention in Boston – find our company in the partnering system for potential meetings with us. Let’s come together to stand up for science!
For more, click here.
So grateful to have been part of the Admare Executive Institute and hear from Gordon McCauley and Max Blouw last week. Sad to see the program end but sending a high five to Cohort V!
For more, click here.
Fran Lasowski and Renaud JACQUEMART will be at the Biomed Israel – 21st National Life Science & Technology Week Conference in Tel Aviv this week, a trailblazing platform in the life science industry, showcasing breakthrough Medical Technologies, where Innovative Start-Ups mingle with Industry leaders. Reach out if you’d like to connect!
For more click here:
Fran Lasowski and Renaud JACQUEMART, PhD, MBA are attending the Sixth Annual Ontario Bioscience Innovation Organization (OBIO) Investment Summit (Feb 8 – 10, 2023). Thanks to Maura Campbell for the warm welcome to what is proving to be an outstanding event. Thanks to all who made this opportunity possible.
For more click here:
Fran Lasowski enjoyed catching up with old McMaster friend Stephen Hanson at the BIOTECanada breakfast at JPM WEEK 2023.
Fran Lasowski and Renaud JACQUEMART are attending #JPMWEEK2023 in San Francisco this week. Reach out if you’d like to meet up!
For more click here:
Fran Lasowski, Heather Sheardown and Renaud JACQUEMART are looking forward to Attending OIS XII in San Diego on December 2 & 3, 2022. Let's meet up if you are going to be there!
For more click here:
We are excited to announce that we have received funding from the McMaster Seed Fund to de-risk our patented mucoadhesive micelle nanoparticle (MNP) technology, initially targeted for the treatment of glaucoma.
For more click here:
Frances Lasowski of 20|20 OptimEyes was recently nominated for Innovator of the Year for the 2022 Mcmaster University Innovation Showcase.
For more click here:
Thanks to Laura Müller and Florian Settele for the tour of Navigo Proteins GmbH last week. Navigo Proteins GmbH's Precision Capturing technology can help change the paradigm in #biomanufacturing and make things happen for next generation vaccines! With Renaud JACQUEMART and Fran Lasowski.
For more click here:
20|20 OptimEyes will be at the BIO-Europe Meeting in Leipzig, October 24-26, 2022. Contact Fran Lasowski if you are able to connect!
For more click here:
We are excited to receive funding from the Ontario Bioscience Innovation Organization Business Development Skills Program (BDSP), 2022 competition. The BDSP provides financial support for companies to access training courses and knowledge transfer opportunities from subject matter experts in areas specific to intellectual property commercialization. What a great opportunity! Thanks, OBIO!
For more click here:
We are excited to be presenting to global investors at the 2022 OBIO Investment Summit (hosted online), February 9-11. Investors should register for the Summit to meet with Canada’s most investable venture companies and connect with emerging companies at Canada’s top research institutions.
For more click here:
Dr. Frances Lasowski, co-founder and CEO, was honoured to have the opportunity to present on 20|20 OptimEyes’ micelle technology at the Ophthalmic Innovation Summit @ SECO in Atlanta in March 2020.
20|20 OptimEyes Technologies is a spin-out company of the Sheardown Lab and C20/20 Innovation Hub.
For more click here:
In August 2020, Dr. Frances Lasowski, co-founder and CEO, presented at the Evolution of Dry Eye Management at OIS@SECO in Atlanta, and was honoured to have the opportunity to discuss her innovative technology.
20|20 OptimEyes Technologies is a spin-out company of the Sheardown Lab and C20/20 Innovation Hub.
For more click here:
We are proud to announce that 20|20 OptimEyes Technologies is officially a graduate of Creative Destruction Lab Vancouver Program, Health Stream.
We are so thankful to all of the stellar content experts and business leaders who have supported and mentored us through the program.
For more click here: